Literature DB >> 23423525

Ambulatory blood pressure improves prediction of cardiovascular risk: implications for better antihypertensive management.

Lawrence R Krakoff1.   

Abstract

Accurate measurement of arterial pressure is necessary for diagnosis of hypertension and for assessment of its therapy. The development and growing application of ambulatory blood pressure monitoring (ABPM) furthers these goals. Use of ABPM has defined white coat hypertension (WCH) and masked hypertension (MH), important prognostic diagnoses. ABPM categorizes blood pressure in several ways that increase accuracy for diagnosis and prediction of cardiovascular risk. Measurements of blood pressure throughout the day, at night during sleep, during the morning surge, and, in some instances selected intervals can be especially valuable for both research and clinical management. ABPM is being explored for its value in measuring pulse pressure and a derived index of arterial stiffness. ABPM has also shown to be valuable for defining the effects of antihypertensive drugs therapy. Results of such studies are crucial for advancing antihypertensive management. This review will summarize the important and emerging role of ABPM in defining risk for cardiovascular disease.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23423525     DOI: 10.1007/s11883-013-0317-9

Source DB:  PubMed          Journal:  Curr Atheroscler Rep        ISSN: 1523-3804            Impact factor:   5.113


  77 in total

1.  Day-night dip and early-morning surge in blood pressure in hypertension: prognostic implications.

Authors:  Paolo Verdecchia; Fabio Angeli; Giovanni Mazzotta; Marta Garofoli; Elisa Ramundo; Giorgio Gentile; Giuseppe Ambrosio; Gianpaolo Reboldi
Journal:  Hypertension       Date:  2012-05-14       Impact factor: 10.190

2.  Cost-effectiveness of ambulatory blood pressure: a reanalysis.

Authors:  Lawrence R Krakoff
Journal:  Hypertension       Date:  2005-12-12       Impact factor: 10.190

3.  The use of ambulatory blood pressure monitoring to improve the accuracy and reduce the numbers of subjects in clinical trials of antihypertensive agents.

Authors:  J Conway; J Johnston; A Coats; V Somers; P Sleight
Journal:  J Hypertens       Date:  1988-02       Impact factor: 4.844

4.  High prevalence of unrecognized sleep apnoea in drug-resistant hypertension.

Authors:  A G Logan; S M Perlikowski; A Mente; A Tisler; R Tkacova; M Niroumand; R S Leung; T D Bradley
Journal:  J Hypertens       Date:  2001-12       Impact factor: 4.844

5.  White coat hypertension diagnosed by 24-h ambulatory monitoring. Examination of 159 newly diagnosed hypertensive patients.

Authors:  A Høegholm; K S Kristensen; N H Madsen; T L Svendsen
Journal:  Am J Hypertens       Date:  1992-02       Impact factor: 2.689

6.  Chronotherapy with valsartan/hydrochlorothiazide combination in essential hypertension: improved sleep-time blood pressure control with bedtime dosing.

Authors:  Ramón C Hermida; Diana E Ayala; Artemio Mojón; María J Fontao; José R Fernández
Journal:  Chronobiol Int       Date:  2011-08-08       Impact factor: 2.877

7.  Principal results of the Controlled Onset Verapamil Investigation of Cardiovascular End Points (CONVINCE) trial.

Authors:  Henry R Black; William J Elliott; Gregory Grandits; Patricia Grambsch; Tracy Lucente; William B White; James D Neaton; Richard H Grimm; Lennart Hansson; Yves Lacourciere; James Muller; Peter Sleight; Michael A Weber; Gordon Williams; Janet Wittes; Alberto Zanchetti; Robert J Anders
Journal:  JAMA       Date:  2003 Apr 23-30       Impact factor: 56.272

8.  Low diastolic ambulatory blood pressure is associated with greater all-cause mortality in older patients with hypertension.

Authors:  Andrea Ungar; Giuseppe Pepe; Lorella Lambertucci; Angela Fedeli; Matteo Monami; Edoardo Mannucci; Luciano Gabbani; Giulio Masotti; Niccolò Marchionni; Mauro Di Bari
Journal:  J Am Geriatr Soc       Date:  2009-02       Impact factor: 5.562

9.  Adverse prognostic value of a blunted circadian rhythm of heart rate in essential hypertension.

Authors:  P Verdecchia; G Schillaci; C Borgioni; A Ciucci; M P Telera; S Pede; R Gattobigio; C Porcellati
Journal:  J Hypertens       Date:  1998-09       Impact factor: 4.844

10.  Prognostic influence of office and ambulatory blood pressures in resistant hypertension.

Authors:  Gil F Salles; Claudia R L Cardoso; Elizabeth S Muxfeldt
Journal:  Arch Intern Med       Date:  2008-11-24
View more
  7 in total

Review 1.  Time to re-evaluate effects of renin-angiotensin system inhibitors on renal and cardiovascular outcomes in diabetic nephropathy.

Authors:  Hiromichi Suzuki; Tomohiro Kikuta; Tsutomu Inoue; Ukihiro Hamada
Journal:  World J Nephrol       Date:  2015-02-06

Review 2.  Reducing health disparities: the role of sleep deficiency and sleep disorders.

Authors:  Aaron D Laposky; Eve Van Cauter; Ana V Diez-Roux
Journal:  Sleep Med       Date:  2015-02-27       Impact factor: 3.492

3.  Association of nocturnal blood pressure patterns with inflammation and central and peripheral estimates of vascular health in rheumatoid arthritis.

Authors:  Eugenia Gkaliagkousi; Panagiota Anyfanti; Sophia Chatzimichailidou; Areti Triantafyllou; Antonios Lazaridis; Spyros Aslanidis; Stella Douma
Journal:  J Hum Hypertens       Date:  2018-03-09       Impact factor: 3.012

4.  Institutional Guidelines for Resistance Exercise Training in Cardiovascular Disease: A Systematic Review.

Authors:  Andressa Santoro Faber Fidalgo; Paulo Farinatti; Juliana Pereira Borges; Tainah de Paula; Walace Monteiro
Journal:  Sports Med       Date:  2019-03       Impact factor: 11.136

Review 5.  Ambulatory blood pressure monitoring in clinical practice: a review.

Authors:  J Rick Turner; Anthony J Viera; Daichi Shimbo
Journal:  Am J Med       Date:  2014-08-12       Impact factor: 4.965

6.  Blood Pressure Measurement Modalities: A Primer for Busy Practitioners.

Authors:  L Allen Kindman; J Rick Turner; John Lee
Journal:  J Clin Hypertens (Greenwich)       Date:  2015-11-12       Impact factor: 3.738

Review 7.  Ambulatory blood pressure monitoring over 24 h: A Latin American Society of Hypertension position paper-accessibility, clinical use and cost effectiveness of ABPM in Latin America in year 2020.

Authors:  Ramiro A Sánchez; José Boggia; Ernesto Peñaherrera; Weimar Sebba Barroso; Eduardo Barbosa; Raúl Villar; Leonardo Cobos; Rafael Hernández Hernández; Jesús Lopez; José Andrés Octavio; José Z Parra Carrillo; Agustín J Ramírez; Gianfranco Parati
Journal:  J Clin Hypertens (Greenwich)       Date:  2020-02-12       Impact factor: 3.738

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.